HIF-1 2α-IN-2 is a potent inhibitor of HIF-1 2α, which effectively reduces the levels of HIF-1 2α. This compound elicits an iron starvation response by specifically targeting ISCA2, a key proteininvolved in Iron Sulfur Cluster Assembly 2. [1]
dMCL1-2 is a potent and selective myeloid leukemia 1 (MCL1) degrading agent based on PROTAC, which binds to MCL1 with a KD of 30 nM. dmcl-2 activates the apoptosis mechanism by degrading MCL1.This compound is unstable in powder form and other related salt forms are recommended.
ERK1 2 inhibitor 1 is a potent, orally bioavailable ERK1 2 inhibitor, showing 60% inhibition at 1 nM and an IC50 of 3.0 nM against ERK1 and ERK2, respectively.